Scientists test 'Double Punch' cell therapy to stop Leukemia's return
NCT ID NCT07328503
Summary
This study is testing whether a second, different type of CAR T-cell therapy can help keep a type of blood cancer (acute lymphoblastic leukemia) from coming back for a longer time. It is for children and adults whose cancer went away after a first CAR T-cell treatment but who are at high risk of it returning. Researchers will collect and modify the participant's own immune cells to target a different marker on the cancer cells, aiming to extend the period of remission.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.